Published in Cell on July 25, 1997
Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev (2008) 3.07
Identification of endogenous retroviral reading frames in the human genome. Retrovirology (2004) 2.58
Bacterial superantigens. Clin Exp Immunol (2003) 2.42
Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol (1999) 2.29
Human-specific integrations of the HERV-K endogenous retrovirus family. J Virol (1998) 2.25
Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci U S A (2001) 1.82
ERV-L elements: a family of endogenous retrovirus-like elements active throughout the evolution of mammals. J Virol (1999) 1.70
The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J Virol (2002) 1.49
Physiological knockout of the envelope gene of the single-copy ERV-3 human endogenous retrovirus in a fraction of the Caucasian population. J Virol (1998) 1.44
Demystified. Human endogenous retroviruses. Mol Pathol (2003) 1.41
Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol (1999) 1.39
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med (1998) 1.39
Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus. J Virol (1999) 1.35
HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease. Front Oncol (2013) 1.30
Proviral structure, chromosomal location, and expression of HERV-K-T47D, a novel human endogenous retrovirus derived from T47D particles. J Virol (1998) 1.13
Identification and characterization of two closely related unclassifiable endogenous retroviruses in pythons (Python molurus and Python curtus). J Virol (2002) 1.09
Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax (2000) 1.05
Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor. J Exp Med (1998) 1.03
Human endogenous retroviruses: transposable elements with potential? Clin Exp Immunol (2004) 1.03
Virus infections in type 1 diabetes. Cold Spring Harb Perspect Med (2012) 1.01
Genome-wide expression profiles of endogenous retroviruses in lymphoid tissues and their biological properties. Virology (2008) 0.98
Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis. Bioessays (2013) 0.98
Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis. Mult Scler (2008) 0.94
Age-dependent tolerance to an endogenous tumor-associated antigen. Vaccine (2008) 0.92
Retroviruses and the pathogenesis of schizophrenia. Proc Natl Acad Sci U S A (2001) 0.88
Superantigens in human disease. J Clin Immunol (1999) 0.88
Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia. Schizophr Bull (2010) 0.88
Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis. PLoS One (2013) 0.88
Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin Exp Immunol (2002) 0.88
Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene. J Virol (1998) 0.87
Regulatory activities of transposable elements: from conflicts to benefits. Nat Rev Genet (2016) 0.87
Lipid-derived free radical production in superantigen-induced interstitial pneumonia. Free Radic Biol Med (2009) 0.85
Expression profiling of repetitive elements by melting temperature analysis: variation in HERV-W gag expression across human individuals and tissues. BMC Genomics (2009) 0.85
The role of environmental factors in insulin-dependent diabetes mellitus: an unresolved issue. Environ Health Perspect (1999) 0.84
Divergent and dynamic activity of endogenous retroviruses in burn patients and their inflammatory potential. Exp Mol Pathol (2014) 0.83
Genome-wide changes in expression profile of murine endogenous retroviruses (MuERVs) in distant organs after burn injury. BMC Genomics (2007) 0.83
Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays. Diabetes (2015) 0.82
Type I diabetes mellitus: genetic factors and presumptive enteroviral etiology or protection. J Pathog (2014) 0.82
Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases. Arthritis Res (2002) 0.82
Genetics of graft-versus-host disease, I. A locus on chromosome 1 influences development of acute graft-versus-host disease in a major histocompatibility complex mismatched murine model. Immunology (1999) 0.82
Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signaling. J Immunol (2014) 0.80
Establishing the baseline level of repetitive element expression in the human cortex. BMC Genomics (2011) 0.79
An alternative approach to medical genetics based on modern evolutionary biology. Part 3: HERVs in diseases. J R Soc Med (2009) 0.79
Pathological and evolutionary implications of retroviruses as mobile genetic elements. Genes (Basel) (2013) 0.77
Viruses and diabetes: is there something sweet about hepatitis C infection? Ochsner J (2001) 0.77
Paradigms in multiple sclerosis: time for a change, time for a unifying concept. Inflammopharmacology (2011) 0.77
The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention. Clin Epigenetics (2011) 0.75
Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases. Biomed Res Int (2017) 0.75
Functional analysis of the env open reading frame in human endogenous retrovirus IDDMK(1,2)22 encoding superantigen activity. J Virol (2000) 0.75
Response of T-cell subpopulations to superantigen and recall antigen stimulation in systemic sclerosis. Indian J Dermatol (2012) 0.75
Novel procedures for high-throughput analysis of a frequent insertion-deletion polymorphism in the human T-cell receptor beta locus. Immunogenetics (2004) 0.75
An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes. JCI Insight (2017) 0.75
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (1984) 11.30
Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science (1984) 5.43
A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature (1982) 5.12
Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell (1993) 4.80
Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet (1984) 3.77
Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science (1994) 3.71
Insertion of a rabbit beta-globin gene sequence into an E. coli plasmid. Nucleic Acids Res (1975) 3.66
Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes. EMBO J (1983) 3.36
Purification of 14S messenger RNA of immunoglobulin light chain that codes for a possible light-chain precursor. Proc Natl Acad Sci U S A (1973) 3.25
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol (2001) 3.14
Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell (1988) 3.09
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med (1985) 2.95
Identification of HIV-infected seronegative individuals by a direct diagnostic test based on hybridisation to amplified viral DNA. Lancet (1988) 2.72
Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature (2000) 2.57
Allelic polymorphism and complexity of the genes for HLA-DR beta-chains--direct analysis by DNA-DNA hybridization. Nature (1982) 2.34
A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev (1995) 2.33
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med (1985) 2.20
Isolation of cDNA clones encoding HLA-DR alpha chains. Proc Natl Acad Sci U S A (1982) 2.17
A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature (1985) 2.16
Cloning and amplification of alpha and beta mouse globin gene sequences synthesised in vitro. Gene (1977) 2.03
Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity (1998) 2.02
Nomenclature for factors of the HLA system, 1990. Tissue Antigens (1991) 1.98
Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. Proc Natl Acad Sci U S A (1989) 1.92
MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain. Genes Dev (1990) 1.92
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Detectionof reverse transcriptase activity in live attenuated virus vaccines. Clin Diagn Virol (1996) 1.87
A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet (1998) 1.84
Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci U S A (1994) 1.84
Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs. Cell (1986) 1.82
Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J (1986) 1.82
Isolation of distinct cDNA clones encoding HLA-DR beta chains by use of an expression assay. Proc Natl Acad Sci U S A (1982) 1.77
Stepwise biosynthesis in vitro of globin genes from globin mRNA by DNA polymerase of avian myeloblastosis virus. Proc Natl Acad Sci U S A (1976) 1.75
The complete sequence of the mRNA for the HLA-DR-associated invariant chain reveals a polypeptide with an unusual transmembrane polarity. EMBO J (1984) 1.72
RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res (1996) 1.71
Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr (2000) 1.69
Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis (1994) 1.69
Induction of human interleukin 1 mRNA measured by collagenase- and prostaglandin E2-stimulating activity in rheumatoid synovial cells. Eur J Immunol (1984) 1.66
RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol Cell Biol (1994) 1.66
Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J Exp Med (1986) 1.61
Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N Engl J Med (1997) 1.60
Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc Natl Acad Sci U S A (1994) 1.59
Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis (1999) 1.58
Isolation of poly(adenylic acid)-rich ribonucleic acid from mouse myeloma and synthesis of complementary deoxyribonucleic acid. Biochemistry (1973) 1.58
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens (1992) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Polymorphism of human Ia antigens: gene conversion between two DR beta loci results in a new HLA-D/DR specificity. Nature (1986) 1.57
Cloning of immunoglobulin kappa light chain genes from mouse liver and myeloma MOPC 173. Nucleic Acids Res (1979) 1.54
Molecular cloning of glucokinase cDNA. Developmental and dietary regulation of glucokinase mRNA in rat liver. J Biol Chem (1987) 1.53
Molecular organization of the HLA-SB region of the human major histocompatibility complex and evidence for two SB beta-chain genes. Proc Natl Acad Sci U S A (1984) 1.51
Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS (1997) 1.50
Induction of HLA class II genes by IFN-gamma is transcriptional and requires a trans-acting protein. J Immunol (1989) 1.46
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol Cell Biol (1993) 1.46
Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med (1994) 1.46
Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line. EMBO J (1982) 1.46
Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA class II gene family. Immunogenetics (1984) 1.45
RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J (1997) 1.45
A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha. J Immunol (1987) 1.44
Estimation of the number of genes coding for the constant part of the mouse immunoglobulin kappa light chain. Proc Natl Acad Sci U S A (1974) 1.42
Cloning and amplification of rabbit alpha- and beta-globin gene sequences into Escherichia coli plasmids. J Biol Chem (1977) 1.41
Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. J Infect Dis (2000) 1.41
False-positive HIV-1 virus cultures using whole blood. AIDS (1992) 1.40
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
Absence of DRw15/3 and of DRw15/7 heterozygotes in Caucasian patients with systemic lupus erythematosus. Tissue Antigens (1991) 1.39
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol Cell Biol (1996) 1.37
Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. J Virol Methods (1999) 1.36
Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic Rev (1989) 1.35
Nomenclature for factors of the HLA system, 1995. Tissue Antigens (1995) 1.34
A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J Clin Invest (1985) 1.34
Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX. Mol Cell Biol (1994) 1.30
Antibodies against three purified proteins of the human type C retrovirus, human T-cell leukemia-lymphoma virus, in adult T-cell leukemia-lymphoma patients and healthy Blacks from the Caribbean. Cancer Res (1983) 1.30
Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. J Med Virol (2001) 1.28
Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens. Proc Natl Acad Sci U S A (1983) 1.27
Enzymatic synthesis of DNA complementary to purified 14S messenger RNA of immunoglobulin light chain. Proc Natl Acad Sci U S A (1973) 1.24
Biosynthesis of RNA in antibody-producing tissues. Proc Natl Acad Sci U S A (1965) 1.23
Transcriptional regulation of HLA class II and invariant chain genes. J Immunol (1985) 1.23
Expression of HLA-DR antigens at the surface of mouse L cells co-transfected with cloned human genes. Nature (1983) 1.22
Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol Cell Biol (1990) 1.22
HLA-DR polymorphism in a Senegalese Mandenka population: DNA oligotyping and population genetics of DRB1 specificities. Am J Hum Genet (1992) 1.22
Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J Biol Chem (1994) 1.21
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein. Science (1984) 1.21
No detectable reiteration of genes coding for mouse MOPC 41 immunoglobulin light-chain mRNA. Proc Natl Acad Sci U S A (1976) 1.20
Nomenclature for factors of the HLA system, 1994. Tissue Antigens (1994) 1.19
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Somatic mutations of immunoglobulin variable genes are restricted to the rearranged V gene. Science (1983) 1.17
Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency. N Engl J Med (1988) 1.17
High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr (1999) 1.17
Nomenclature for factors of the HLA system, 1995. Hum Immunol (1995) 1.16
A new nonsense mutation as the molecular basis for beta thalassaemia. J Mol Biol (1982) 1.15